MedTrace Logo

Epidemiology of Treatment Resistant Depression in Taiwan

NCT02691520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8356

Last updated 2024-10-28

No results posted yet for this study

Summary

The purpose of this study is to assess the epidemiology of Treatment Resistant Depression (TRD) in the nationally insured population in Taiwan including incidence, duration of clinical episodes, and prevalence by age and sex.

Conditions

  • Depressive Disorder, Treatment-Resistant

Sponsors & Collaborators

  • Elysia Group

    collaborator UNKNOWN

  • Janssen Research & Development, LLC

    lead INDUSTRY

Principal Investigators

  • Janssen Research & Development, LLC Clinical Trial · Janssen Research & Development, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-29
Primary Completion
2016-02-18
Completion
2016-02-18

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02691520 on ClinicalTrials.gov